Chris Cline, CFA in

Chris Cline, CFA

Chief Financial Officer at Travere Therapeutics
📍 New York, New York, United States

Chris Cline is the Chief Financial Officer at Travere Therapeutics, where he has held progressing roles since 2014, starting in investor relations. A Chartered Financial Analyst, he holds a BSBA from Xavier Universitys Williams College of Business and has prior experience at Elan Corporation and Phase Forward.

He is passionate about developing and delivering innovative treatments to people living with rare diseases, a commitment reflected in his companys mission and his own public statements.

His career path is unique, having advanced from leading investor relations and corporate communications to becoming the companys CFO.

Read the full overview →
Experience
20 Years
Current Role
Chief Financial Officer
Job Level
Leadership
Location
New York, New York, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities

Topics Chris cares about

Rare Disease Treatment
He is a leader at a biopharmaceutical company focused on delivering therapies for rare kidney and metabolic diseases and shares posts about this mission.
Corporate Finance
As CFO and a CFA charterholder, he oversees corporate and strategic finance, planning, and analysis for a public biopharmaceutical company.
+5 more topics Login to view topics
Career

Work history

9-2022
Chief Financial Officer
Travere Therapeutics
9-2019 - 9-2022
Senior Vice President, Investor Relations & Corporate Communications
Travere Therapeutics
4-2017 - 9-2019
Vice President, Investor Relations & Corporate Communications
Travere Therapeutics
4-2016 - 4-2017
Senior Director, Investor Relations
Travere Therapeutics
7-2015 - 4-2016
Director, Investor Relations
Travere Therapeutics
In the press

Media appearances

Travere Therapeutics CFO sells shares to cover tax obligation. Featured in Investing.com
See now
Travere Therapeutics Announces Plan for Chief Financial Officer Transition. Featured in CityBiz
+4 more appearances Login to view media
Education
2002 - 2006
BSBA
Xavier University - Williams College of Business
Education details unavailable
St. George's School
Social presence
in

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Chris. Free, 10 seconds.